National Stroke Research Institute, Florey Neuroscience Institutes, Melbourne, Australia.
Stroke. 2011 Sep;42(9):2642-4. doi: 10.1161/STROKEAHA.111.619486. Epub 2011 Jul 14.
Cognitive function is often ignored in stroke research trials. The brief Montreal Cognitive Assessment (MoCA) may be sensitive to stroke-related cognitive deficits.
We evaluated the feasibility of administering the MoCA at 3 months in a large stroke trial (A Very Early Rehabilitation Trial [AVERT]).
Data (blinded to intervention group) are presented for 294 patients with mean age of 70.6 years (SD, 12.8); 220 (75%) completed the MoCA, 54 (18%) had missing data, and 20 (7%) had died. Of those surviving to 3 months, the MoCA was completed by 87% with mild stroke, 79% with moderate stroke, and 67% with severe stroke on admission. Mean MoCA score was 21.1 (SD 7.5) out of 30; only 78 of 220 (35%) patients attained the "normal" cutoff (≥26).
The MoCA is a feasible global cognitive screening tool in stroke trials. Clinical Trial Registration- URL: www.anzctr.org.au/trial_view.aspx?ID=1266. Unique identifier: ACTRN12606000185561.
认知功能在中风研究试验中经常被忽视。简短蒙特利尔认知评估(MoCA)可能对与中风相关的认知缺陷敏感。
我们评估了在一项大型中风试验(早期康复试验[AVERT])中在 3 个月时进行 MoCA 测试的可行性。
数据(对干预组进行盲法评估)呈现给 294 名平均年龄为 70.6 岁(标准差,12.8)的患者;220 名(75%)完成了 MoCA,54 名(18%)数据缺失,20 名(7%)死亡。在存活至 3 个月的患者中,轻度中风患者中有 87%完成了 MoCA,中度中风患者中有 79%,重度中风患者中有 67%。MoCA 平均得分为 30 分中的 21.1(标准差 7.5);220 名患者中只有 78 名(35%)达到“正常”截止值(≥26)。
MoCA 是中风试验中一种可行的全面认知筛查工具。临床试验注册- URL:www.anzctr.org.au/trial_view.aspx?ID=1266. 独特标识符:ACTRN12606000185561.